Page last updated: 2024-08-17

methylene blue and Leigh Disease

methylene blue has been researched along with Leigh Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bouchard, L; Côté, I; Larouche, PL; Legault, J; Morin, C; Pichette, A; Robinson, BH	1

Other Studies

1 other study(ies) available for methylene blue and Leigh Disease

Article	Year
Low-concentration methylene blue maintains energy production and strongly improves survival of Leigh syndrome French Canadian skin fibroblasts. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2011, Volume: 14, Issue:3 Topics: Adenosine Triphosphate; Cell Line; Cell Survival; Cytochrome-c Oxidase Deficiency; Dose-Response Relationship, Drug; Electron Transport Complex IV; Energy Metabolism; Fibroblasts; Heterozygote; Homozygote; Humans; Hydrogen-Ion Concentration; Leigh Disease; Methylene Blue; Mutation; Neoplasm Proteins; Skin; Time Factors	2011

Article

Year

Low-concentration methylene blue maintains energy production and strongly improves survival of Leigh syndrome French Canadian skin fibroblasts.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2011, Volume: 14, Issue:3

Topics: Adenosine Triphosphate; Cell Line; Cell Survival; Cytochrome-c Oxidase Deficiency; Dose-Response Relationship, Drug; Electron Transport Complex IV; Energy Metabolism; Fibroblasts; Heterozygote; Homozygote; Humans; Hydrogen-Ion Concentration; Leigh Disease; Methylene Blue; Mutation; Neoplasm Proteins; Skin; Time Factors

2011